XML 18 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT - USD ($)
$ in Millions
Total
Total INNOVATE Stockholders' (Deficit) Equity
Common Stock
Additional Paid-In Capital
Treasury Stock
Accumulated Deficit
Accumulated Comprehensive Income (Loss)
 [1]
Non-controlling Interest
Temporary Equity
Beginning balance (in shares) at Dec. 31, 2022     78,800,000            
Beginning balance at Dec. 31, 2022 $ (90.6) $ (121.3) $ 0.1 $ 330.1 $ (5.3) $ (452.1) $ 5.9 $ 30.7  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Share-based compensation 0.5 0.5   0.5          
Preferred stock dividends - paid (0.9) (0.9)   (0.9)         $ (0.3)
Taxes paid in lieu of shares issued for share-based compensation (in shares)     (100,000)            
Taxes paid in lieu of shares issued for share-based compensation (0.1) (0.1)     (0.1)        
Issuance of common stock (in shares)     300,000            
Distributions to non-controlling interests (10.7)             (10.7) (5.2)
Transactions with non-controlling interests 0.1 (2.9)   (2.9)       3.0 0.1
Net (loss) income (6.8) (9.0)       (9.0)   2.2  
Other comprehensive loss (9.6) (7.4)         (7.4) (2.2) (0.5)
Ending balance (in shares) at Mar. 31, 2023     79,000,000.0            
Ending balance at Mar. 31, 2023 (118.1) (141.1) $ 0.1 326.8 (5.4) (461.1) (1.5) 23.0  
Beginning balance at Dec. 31, 2022                 61.0
Increase (Decrease) in Temporary Equity [Roll Forward]                  
DBMGi preferred stock reclass to liability (41.8)                
Net loss                 (1.2)
Ending balance at Mar. 31, 2023                 12.1
Beginning balance (in shares) at Dec. 31, 2022     78,800,000            
Beginning balance at Dec. 31, 2022 $ (90.6) (121.3) $ 0.1 330.1 (5.3) (452.1) 5.9 30.7  
Ending balance (in shares) at Dec. 31, 2023 79,234,991   79,200,000            
Ending balance at Dec. 31, 2023 $ (151.7) (165.5) $ 0.1 328.2 (5.4) (487.3) (1.1) 13.8  
Beginning balance at Dec. 31, 2022                 61.0
Ending balance at Dec. 31, 2023 15.4               15.4
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Share-based compensation 0.4 0.4   0.4          
Preferred stock dividends - accrued (0.3) (0.3)   (0.3)          
Preferred stock dividends - paid 0.0               (0.3)
Issuance of common stock (in shares)     700,000            
Rights offering and private placement transaction costs (0.5) (0.5)   (0.5)         (1.3)
Other (0.1) (0.1)   (0.1)          
Net (loss) income (19.9) (17.4)       (17.4)   (2.5)  
Other comprehensive loss $ (1.1) (1.0)         (1.0) (0.1) 0.0
Ending balance (in shares) at Mar. 31, 2024 79,885,927   79,900,000            
Ending balance at Mar. 31, 2024 $ (173.2) $ (184.4) $ 0.1 $ 327.7 $ (5.4) $ (504.7) $ (2.1) $ 11.2  
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Issuance of preferred stock in private placement 25.0                
Other                 0.0
Net loss                 (0.2)
Ending balance at Mar. 31, 2024 $ 38.6               $ 38.6
[1]
(a) Inclusive of other comprehensive loss, foreign currency cumulative translation adjustments totaled a loss of $3.3 million and $2.4 million as of March 31, 2024 and December 31, 2023, respectively.